Seoul, South Korea

Hyockman Kwon

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Aliad Biopharma. Active years: 2026.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hyockman Kwon: Innovator in Neurodegenerative Disease Treatment

Introduction

Hyockman Kwon is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of nervous system diseases. His innovative work focuses on developing compounds that can effectively address neurodegenerative conditions.

Latest Patents

Hyockman Kwon holds 1 patent for his invention titled "Composition for preventing or treating nervous system diseases comprising compound that inhibits mTOR signaling pathway as active ingredient." This patent describes a novel compound that inhibits the mTOR signaling pathway, which is crucial for various cellular processes. The compound has been shown to inhibit mTORC1 and mTORC2 activities, activate autophagy, and alleviate symptoms associated with Alzheimer's-type dementia in model animals. This pharmaceutical composition has the potential to prevent or treat a range of neurodegenerative diseases and mTORopathies.

Career Highlights

Kwon is currently associated with Aliad Biopharma, where he continues to advance his research and development efforts. His work is pivotal in creating effective treatments for conditions that affect the nervous system. His dedication to innovation in this field has positioned him as a key figure in pharmaceutical research.

Collaborations

Hyockman Kwon collaborates with talented professionals in his field, including Yunhee Kim and Young Taek Han. These collaborations enhance the research and development process, leading to more effective solutions for treating nervous system diseases.

Conclusion

Hyockman Kwon's contributions to the field of neurodegenerative disease treatment through his innovative patent and work at Aliad Biopharma highlight his commitment to improving healthcare. His research has the potential to make a significant impact on the lives of those affected by these challenging conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…